Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
39 studies found for:    " January 20, 2010":" February 19, 2010"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Show Display Options
RSS Create an RSS feed from your search for:
" January 20, 2010":" February 19, 2010"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Completed HIV Treatment and CVD Events
Conditions: HIV Infection;   Cardiovascular Disease;   Infection, Human Immunodeficiency Virus;   Acute Myocardial Infarction
Intervention: Drug: HAART Treatment
2 Unknown  Community-based Accompaniment With Supervised Antiretrovirals in Lima, Peru
Conditions: HIV;   AIDS;   HIV Infections
Intervention: Other: DOT-HAART
3 Withdrawn An Open-label Trial of the Effect of Valacyclovir on Plasma HIV-1 Levels Among HIV-1 Seropositive and HSV-1/2 Seronegative Persons
Conditions: HIV;   HIV Infections
Intervention: Drug: Valacyclovir
4 Completed HIV Vaccine Study in HIV Positive Patients
Condition: HIV Infections
Interventions: Biological: HIV-v (Low Dose);   Biological: HIV-v (High Dose);   Biological: HIV-v (Control)
5 Completed A Safety Study of Dapivirine Vaginal Ring in Africa
Condition: HIV Infections
Interventions: Other: Dapivirine;   Other: Placebo
6 Unknown  Metabolic Safety of Raltegravir Versus Darunavir in HIV Naive Patients
Conditions: Cardiovascular Disease;   HIV Infections
7 Completed Examining the Role of Genetics in Determining the Immune Response to an HIV Vaccine in HIV-Uninfected Adult Twins
Condition: HIV Infections
Interventions: Biological: HIV-1 DNA plasmid vaccine;   Biological: HIV-1 recombinant Ad5 vaccine
8 Unknown  Evaluation of the Efficacy of Hydroxychloroquine in Decreasing Immune Activation in Asymptomatic HIV-infected Patients
Condition: HIV Infections
Interventions: Drug: Hydroxychloroquine;   Drug: Placebo
9 Terminated Kaletra and Maraviroc in Antiretroviral Therapy (ART)-Naive Patients (KALMAR Study)
Condition: HIV Infections
Intervention: Drug: lopinavir/ritonavir plus maraviroc
10 Completed Effect Of Maraviroc On The Pharmacokinetics Of Digoxin
Conditions: Healthy;   HIV Infections
Interventions: Drug: Digoxin;   Drug: Maraviroc
11 Active, not recruiting Investigator-Sponsored Protocol - Continued Use of Ibalizumab
Condition: HIV Infections
Intervention: Drug: ibalizumab
12 Completed Telephone Based Cognitive Behavioral Therapy for HIV Related Depression
Conditions: Depression;   HIV Infections
Interventions: Behavioral: Telephone-based CBT;   Behavioral: Enhanced Usual Care
13 Completed Stocrin Re-examination Study (0831-028)
Condition: HIV Infection
14 Completed Raltegravir Treatment in Patients Failing Highly Active Antiretroviral Therapy (HAART) in Denmark
Condition: HIV Infections
15 Completed Adherence Intervention for People With Low-literacy
Condition: HIV Infections
Interventions: Behavioral: Stick To It;   Behavioral: Standard medication adherence counseling;   Behavioral: Health Counseling
16 Completed HIV Prevention Intervention for People Living With HIV/AIDS
Condition: HIV Infections
Interventions: Behavioral: In The Mix;   Behavioral: Information Support Group
17 Completed The Impact of Short Message Services (SMS) on ARV Adherence in Western Kenya
Conditions: AIDS;   Antiretroviral Therapy;   Medication Adherence;   HIV Infections
Intervention: Behavioral: Short Message Services to Support ARV therapy adherence
18 Completed Drug Interaction Study Between GSK1349572 and Tipranavir/Ritonavir in Healthy Volunteers
Condition: HIV Infections
Intervention: Drug: GSK1349572
19 Completed A Pilot Study of the Effect of Minocycline on Cerebrospinal Fluid HIV-1 Infection
Condition: HIV Infection
Intervention: Drug: Minocycline
20 Completed Alcohol Pharmacotherapy for HIV+ Prisoners
Conditions: Alcohol Dependence;   Problem Drinking;   Hazardous Drinking;   Human Immunodeficiency Virus;   AIDS
Interventions: Drug: Vivitrol- Intramuscular naltrexone (depot-formulation);   Drug: Placebo

   Previous Page Studies Shown (1-20) Next Page (21-39) Show next page of results    Last Page
Indicates status has not been verified in more than two years